Neuvior Pharmaceuticals

Neuvior Pharmaceuticals has secured £99,000 in funding from Scottish Enterprise to support a feasibility study for its AI-enabled technology.

Summary of transaction details:

• Value: £99,000
• Sector: Pharmaceutical
• Advisor: None
• Key Entities: Neuvior Pharmaceuticals, Scottish Enterprise
• Location: Glasgow, Scotland

Note: The funding will support Neuvior's nine-month feasibility study exploring how its artificial intelligence-enabled technology can help the NHS identify, assess and deploy generic medicines, and is a strategic move to support the development of AI-enabled technologies in the pharmaceutical sector.